Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.29
+0.23 (2.85%)
Aug 5, 2026, 2:41 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $243.57 million as of August 5, 2026. Its market cap has decreased by -24.80% in one year.
Market Cap
243.57M
Enterprise Value
135.91M
1-Year Change
-24.80%
Ranking
Category
Stock Price
$8.29
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $243.57M, an increase of 46.67%. That is a compound annual growth rate of 15.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 243.57M | 29.92% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 246.71M |
| Capricor Therapeutics | 243.23M |
| MacroGenics | 242.81M |
| ProQR Therapeutics | 241.32M |
| Adagene | 239.84M |
| Compugen | 225.11M |
| Protara Therapeutics | 223.13M |
| Coherus Oncology | 222.12M |